| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 5.151 | 29.795 | 48.224 | 44.140 | 11.159 | 0 | 2.758 | 175 |
| Total Income - EUR | 0 | 0 | 5.151 | 29.837 | 48.224 | 44.140 | 11.159 | 8 | 2.782 | 185 |
| Total Expenses - EUR | 58 | 58 | 1.210 | 18.011 | 28.665 | 31.699 | 13.027 | 2.250 | 11.571 | 10.422 |
| Gross Profit/Loss - EUR | -58 | -58 | 3.942 | 11.827 | 19.559 | 12.441 | -1.868 | -2.242 | -8.789 | -10.237 |
| Net Profit/Loss - EUR | -58 | -58 | 3.890 | 11.528 | 19.077 | 12.033 | -1.980 | -2.242 | -8.818 | -10.239 |
| Employees | 0 | 0 | 1 | 2 | 3 | 3 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ayushfarma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 1.060 | 459 | 0 | 0 | 0 | 0 |
| Current Assets | 44 | 44 | 3.590 | 8.071 | 18.976 | 12.785 | 2.965 | 148 | 4.070 | 170 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 72 | 16 |
| Receivables | 44 | 44 | 1.039 | 1.729 | 1.915 | 3.598 | 42 | 24 | 63 | 84 |
| Cash | 0 | 0 | 2.551 | 6.342 | 17.061 | 9.187 | 2.922 | 124 | 3.935 | 70 |
| Shareholders Funds | -8.617 | -8.587 | -4.485 | 7.125 | 19.203 | 12.157 | 2.848 | -452 | -9.269 | -19.456 |
| Social Capital | 45 | 45 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 8.661 | 8.631 | 8.076 | 1.021 | 1.250 | 1.510 | 124 | 655 | 13.539 | 19.760 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Ayushfarma S.r.l.